Chocry, M.; Leloup, L.; Parat, F.; Messé, M.; Pagano, A.; Kovacic, H.
Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer. Cancers 2022, 14, 5894.
https://doi.org/10.3390/cancers14235894
AMA Style
Chocry M, Leloup L, Parat F, Messé M, Pagano A, Kovacic H.
Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer. Cancers. 2022; 14(23):5894.
https://doi.org/10.3390/cancers14235894
Chicago/Turabian Style
Chocry, Mathieu, Ludovic Leloup, Fabrice Parat, Mélissa Messé, Alessandra Pagano, and Hervé Kovacic.
2022. "Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer" Cancers 14, no. 23: 5894.
https://doi.org/10.3390/cancers14235894
APA Style
Chocry, M., Leloup, L., Parat, F., Messé, M., Pagano, A., & Kovacic, H.
(2022). Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer. Cancers, 14(23), 5894.
https://doi.org/10.3390/cancers14235894